Wilson HTM published yesterday.
They have a 12 month price target of about $1.61 (from memory)
They are assuming that BTA licences LANI for ROW and that a 15% royalty is shared by BTA and DS.
They are assigning a 75% probability to LANI getting FDA approval.
IN OTHER WORDS - THE WILSON HTM TEAM does not recognise that BTA now plans to manage stockpile sales itself, capturing the bulk of the spoils for BTA (and DS).
I think that this is SLOPPY RESEARCH.
- Forums
- ASX - By Stock
- BTA
- biota will enjoy all the spoils-the australian
biota will enjoy all the spoils-the australian, page-6
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online